EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
https://doi.org/10.1038/s41375-021-01161-0
https://doi.org/10.1038/s41375-021-01161-0
Abstract
Description
Funder: MUG (within the PhD program Molecular Medicine)
Funder: Austrian Society of Internal Medicine (Joseph-Skoda Award), Austrian Science Fund (grant P32783), Austrian Society of Hematology and Medical Oncology (Clinical Research Grant) and MEFOgraz
Funder: Austrian Science Fund (grant P 31430-458 B26) and Leukämiehilfe Steiermark
Funder: Austrian Society of Internal Medicine (Joseph-Skoda Award)and Leukämiehilfe Steiermark
Funder: Austrian Society of Internal Medicine (Joseph-Skoda Award), Austrian Science Fund (grant P32783), Austrian Society of Hematology and Medical Oncology (Clinical Research Grant) and MEFOgraz
Funder: Austrian Science Fund (grant P 31430-458 B26) and Leukämiehilfe Steiermark
Funder: Austrian Society of Internal Medicine (Joseph-Skoda Award)and Leukämiehilfe Steiermark